Top

European Radiology

Published in:

01-06-2017 | Interventional

Ethanolgel sclerotherapy of venous malformations improves health-related quality-of-life in adults and children – results of a prospective study

Authors: Walter A. Wohlgemuth, Rene Müller-Wille, Veronika Teusch, Simone Hammer, Moritz Wildgruber, Wibke Uller

Published in: European Radiology | Issue 6/2017

Abstract

Objectives

To assess the treatment-induced changes of health-related quality-of-life (HRQoL) in patients with venous malformations (VM) who underwent ethanol gel sclerotherapy.

Methods

The prospective study in children and adults was approved by the local ethics committee. 31 patients (mean age 23.42 years, range 6.6 – 46.5; 26 female, 5 male) with VM were included. Patients’ self-assessed HRQoL was measured before and after treatment using psychometrically validated questionnaires for adults and children. Differences were analysed with a paired t test.

Results

58 sclerotherapy sessions were performed. The Physical Component Summary (PCS) at baseline was 43.69 and increased significantly (p = 0.01122) to 48.95 after treatment. The bodily pain (BP) scale increased significantly from 37.94 to 48.56 (p = 0.00002), the general health (GH) scale increased significantly from 46.69 to 52.17 (p = 0.00609). Baseline Physical Summary Score (PHS) in children increased significantly after treatment (p < 0.00001) from 25.25 to 45.89. The baseline Psychosocial Summary Score (PSS) in children was 51.08 and increased significantly (p = 0.00031) after treatment to 58.84.

Conclusion

Paediatric and adult patients with VM suffer from bodily pain with overall reduced physical functioning. After sclerotherapy, these restrictions are successfully returning to normal levels with a positive effect on mental and psychosocial domains.

Key points

• Sclerotherapy in venous malformation patients has an unknown effect on health-related quality-of-life

• Prospective study showed improvements in bodily pain and general health in adults

• Children and adults improved from treatment with ethanol gel

• Sclerotherapy is an appropriate therapy

Wassef M, Blei F, Adams D, Alomari A, Baselga E, Berenstein A et al (2015) Vascular anomalies classification: recommendations from the International Society for the Study of Vascular Anomalies. Pediatrics 136:e203–e214

Vogel SA, Hess CP, Dowd CF, Hoffman WY, Kane AJ, Rajaii R et al (2013) Early versus later presentations of venous malformations: where and why? Pediatr Dermatol 30:534–540

Lee BB, Baumgartner I, Berlien P, Bianchini G, Burrows P, Gloviczki P et al (2015) Diagnosis and treatment of venous malformations. Consensus document of the International Union of Phlebology (IUP): updated 2013. Int Angiol 34:97–149

Norgren L, Hiatt WR, Dormandy JA, Nehler MR, Harris KA, Fowkes FG et al (2007) Inter-society consensus for the management of peripheral arterial disease (TASC II). J Vasc Surg 45:S5–S67

Schumacher M, Dupuy P, Bartoli JM, Ernemann U, Herbreteau D, Ghienne C et al (2011) Treatment of venous malformations: first experience with a new sclerosing agent–a multicenter study. Eur J Radiol 80:e366–e372

Sannier K, Dompmartin A, Théron J, Labbé D, Barrellier MT, Leroyer R et al (2004) A new sclerosing agent in the treatment of venous malformations. study on 23 cases. Interv Neuroradiol 10:113–127

Saris-Baglama RN, Dewey CJ, Chisholm GB, Plumb E, King J, Rasicot P et al (2011) Quality metric health outcomes scoring software 4.5 – users guide. Quality Metric Inc. Lincoln

Ware JE Jr, Kosinski M, Dewey JE (2000) How to score version 2 of the SF-36® Health Survey. QualityMetric Inc, Lincoln

Landgraf JM, Abetz L, Ware JE (1996) The CHQ: a user's manual, 1st edn. The Health Institute, Boston

10.

Taft C, Karlsson J, Sullivan M (2001) Do SF-36® summary component scores accurately summarize subscale scores? Qual Life Res 10:395–404CrossRefPubMed

11.

Balakrishnan K, Bauman N, Chun RH, Darrow DH, Grimmer JF, Perkins JA et al (2015) Standardized outcome and reporting measures in pediatric head and neck lymphatic malformations. Otolaryngol Head Neck Surg 152:948–953

12.

Burrows PE, Mason KP (2004) Percutaneous treatment of low flow vascular malformations. J Vasc Interv Radiol 15:431–445CrossRefPubMed

13.

Weinstein JM, Chamlin SL (2005) Quality of life in vascular anomalies. Lymphat Res Biol 8:256–260CrossRef

14.

Van der Pleog HM, van der Ploeg MN, van der Ploeg-Stapert JD (1995) Psychological aspects of the Klippel-Trenaunay syndrome. J Psychosom Res 39:183–191CrossRef

15.

Boetes C, Boll AP, Hartman PH, van Oostrom CG, Rieu PN, de Rooij M et al (1997) Klippel-Trenaunay-type congenital angiodysplasia syndrome; medical and psychological aspects. Ned Tijdschr Geneeskd 141:650–651

16.

Van der Linden E, Pattynama PM, Heeres BC, de Jong SC, Hop WC, Kroft LJ (2009) Long-term patient satisfaction after percutaneous treatment of peripheral vascular malformations. Radiology 251:926–932CrossRefPubMed

17.

Oduber CEU, Khemlani K, Smitt JHS, Hennekam RCM, van der Horst CMAM (2010) Baseline quality of life in patients with Klippel-Trenaunay syndrome. J Plast Reconstruct Aesthet Surg 63:603–609CrossRef

18.

Geirdal AØ, Dheyauldeen S, Bachmann-Harildstad G, Heimdal K (2012) Quality of life in patients with hereditary hemorrhagic telangiectasia in Norway: a population based study. Am J Med Genet A 158A:1269–1278CrossRefPubMed

19.

Breugem CC, Merkus MP, Smitt JH, Legemate DA, van der Horst CM (2004) Quality of life in patients with vascular malformations of the lower extremity. Br J Plast Surg 57:754–763CrossRefPubMed

20.

Rautio R, Laranne J, Kähärä V, Saarinen J, Keski-Nisula L (2004) Long-term results and quality of life after endovascular treatment of venous malformations in the face and neck. Acta Radiol 45:738–745CrossRefPubMed

21.

Rautio R, Saarinen J, Laranne J, Salenius JP, Keski-Nisula L (2004) Endovascular treatment of venous malformations in extremities: results of sclerotherapy and the quality of life after treatment. Acta Radiol 45:397–403CrossRefPubMed

22.

Ware JE Jr, Harris WJ, Gandek B, Rogers BW, Reese PR (1997) MAP-R for Windows: Multitrait/multi-item scale analysis software. Health Assessment Lab, Boston

Title: Ethanolgel sclerotherapy of venous malformations improves health-related quality-of-life in adults and children – results of a prospective study
Authors: Walter A. Wohlgemuth
Rene Müller-Wille
Veronika Teusch
Simone Hammer
Moritz Wildgruber
Wibke Uller
Publication date: 01-06-2017
Publisher: Springer Berlin Heidelberg
Published in: European Radiology / Issue 6/2017
Print ISSN: 0938-7994
Electronic ISSN: 1432-1084
DOI: https://doi.org/10.1007/s00330-016-4603-0

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Ethanolgel sclerotherapy of venous malformations improves health-related quality-of-life in adults and children – results of a prospective study

Abstract

Objectives

Methods

Results

Conclusion

Key points

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Abstract

Objectives

Methods

Results

Conclusion

Key points

Please log in to get access to this content

Other articles of this Issue 6/2017

Diffusion-weighted MR neurography of median and ulnar nerves in the wrist and palm

Prognostic significance of focal lesions and diffuse infiltration on MRI for multiple myeloma: a meta-analysis

Increased susceptibility of asymmetrically prominent cortical veins correlates with misery perfusion in patients with occlusion of the middle cerebral artery

Detection of single-phase CTA occult vessel occlusions in acute ischemic stroke using CT perfusion-based wavelet-transformed angiography

A systematic review and meta-analysis to determine the contribution of mr imaging to the diagnosis of foetal brain abnormalities In Utero

Evaluation of Chondrocalcinosis and Associated Knee Joint Degeneration Using MR Imaging: Data from the Osteoarthritis Initiative